248 related articles for article (PubMed ID: 11855864)
1. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
3. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte differentiation induced by calcium, phorbol ester or interferon-gamma elicits distinct changes in the retinoid signalling pathways.
Karlsson T; Vahlquist A; Törmä H
J Dermatol Sci; 2010 Mar; 57(3):207-13. PubMed ID: 20122816
[TBL] [Abstract][Full Text] [Related]
5. Nuclear retinoid receptors and the transcription of retinoid-target genes.
Bastien J; Rochette-Egly C
Gene; 2004 Mar; 328():1-16. PubMed ID: 15019979
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.
Giannì M; Bauer A; Garattini E; Chambon P; Rochette-Egly C
EMBO J; 2002 Jul; 21(14):3760-9. PubMed ID: 12110588
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
[TBL] [Abstract][Full Text] [Related]
12. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
Osburn DL; Shao G; Seidel HM; Schulman IG
Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
[TBL] [Abstract][Full Text] [Related]
13. Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells.
Ye XF; Liu S; Wu Q; Lin XF; Zhang B; Wu JF; Zhang MQ; Su WJ
World J Gastroenterol; 2003 Sep; 9(9):1915-9. PubMed ID: 12970875
[TBL] [Abstract][Full Text] [Related]
14. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
Dillard AC; Lane MA
Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140.
Chen Y; Hu X; Wei LN
Mol Cell Endocrinol; 2004 Oct; 226(1-2):43-50. PubMed ID: 15489004
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
Zhuang Y; Faria TN; Chambon P; Gudas LJ
Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
[TBL] [Abstract][Full Text] [Related]
17. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
18. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
19. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin.
Karlsson T; Rollman O; Vahlquist A; Törmä H
Acta Derm Venereol; 2004; 84(5):363-9. PubMed ID: 15370702
[TBL] [Abstract][Full Text] [Related]
20. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells.
Tanaka T; Rodríguez de la Concepción ML; De Luca LM
Biochem Pharmacol; 2001 Jun; 61(11):1347-55. PubMed ID: 11331070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
